FindTrial
Sign In

A Pharmaceutico - Analytical Study of Gandirikadya taila and Clinical Evaluation of its Efficacy in the Management of Dadru Kustha(Tinea Corporis)

A pharmaceutico - Analytical Study of Gandirikadya taila and Clinical Evaluation of its Efficacy in the Management of Dadru Kustha(Tinea Corporis) - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/111975
Enrollment
60
Registered
2026-06-04
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

Intervention1: Gandirikadya Malahara: Gandirikadya Malahara is freshly prepared and on affected region. (1)Medicine Name:Gandirikadya Malahara,Reference:Bhaishajya ratnavali kustha chikistha adhyaya(5
15days. Control Intervention1: Gandirikadya taila: Gandirikadya taila prepared and applied on the affected region (1) Medicine Name: Gandirikadya taila,Reference:Bhaishajya ratnavali kustha chikistha

Sponsors

Sri Venkateswara Ayurvedic College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Individuals presenting with classical features of kandu,Raga,Pidaka,Utsana mandala for Dadru Kustha.

Exclusion criteria

Exclusion criteria: Patients with severe systemic disorders such as uncontrolled Diabetes Mellitus, Hypertension, Renal or Hepatic impairment. Patients with STDs / Immunocompromised conditions (e.g., HIV/AIDS, tuberculosis). Patients on long-term corticosteroids or immunosuppressive therapy. Pregnant and lactating women. Patients with other types of Kustha or dermatological conditions other than Tinea infections.

Design outcomes

Primary

MeasureTime frame
To compare the efficacies of gandirikadya taila and malahara in group A and group B in the management of dadru kushtaTimepoint: Group A - At the baseline, 15th day, 30th day and after completion of the treatment. Group - B - At the baseline, 15th day, 30th day and after completion of the treatment.—

Secondary

MeasureTime frame
To compare the efficacies of gandirikadya taila and malahara in group A and group B in the management of dadru kushta and assessment of recurrence after treatment.Timepoint: Group A - At the baseline, 15th day, 30th day and after completion of the treatment. Group - B - At the baseline, 15th day, 30th day and after completion of the treatment.—

Countries

India

Contacts

Public ContactDr Ch Sridurga

Sri Venkateswara Ayurvedic College and Hospital

pennerudurga@gmail.com8919423127

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026